Live Breaking News & Updates on Therapeutics Company Profile|Page 4

Stay updated with breaking news from Therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

10,212 Shares in RAPT Therapeutics, Inc. (NASDAQ:RAPT) Bought by Chesapeake Capital Corp IL

Chesapeake Capital Corp IL purchased a new stake in shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 10,212 shares of the company’s stock, valued at approximately $254,000. Other institutional investors have […] ....

Los Angeles , United States , Leerink Partnrs , Therapeutics Inc , Chesapeake Capital Corp , Sg Americas Securities , China Universal Asset Management Co , Jpmorgan Chase Co , Therapeutics Company Profile , Swiss National Bank , Wolfe Research , Exchange Traded Concepts , Securities Exchange Commission , Los Angeles Capital Management , Free Report , Traded Concepts , Universal Asset Management , National Bank , Angeles Capital Management , Trading Down , Get Free Report ,

PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Average Rating of "Hold" by Brokerages

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) have been given an average rating of “Hold” by the fourteen analysts that are covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and four have issued a buy recommendation on […] ....

United States , Raymond James , Matthewb Klein , Jeromeb Zeldis , Charles Schwab Investment Management Inc , Vise Technologies Inc , Jefferies Financial Group , Goldman Sachs Group , Therapeutics Inc , Rathbones Group , Therapeutics Company Profile , Walleye Capital , Securities Exchange Commission , Get Free Report , Financial Group , Exchange Commission , Director Jerome , Schwab Investment Management , Get Free ,

PTC Therapeutics (NASDAQ:PTCT) Given New $53.00 Price Target at JPMorgan Chase & Co.

PTC Therapeutics (NASDAQ:PTCT – Free Report) had its target price hoisted by JPMorgan Chase & Co. from $43.00 to $53.00 in a research report released on Tuesday morning, Benzinga reports. They currently have an overweight rating on the biopharmaceutical company’s stock. A number of other brokerages also recently weighed in on PTCT. Cantor Fitzgerald reissued […] ....

United States , Jeromeb Zeldis , Raymond James , Matthewb Klein , Jpmorgan Chase Co , Jefferies Financial Group , Hexagon Capital Partners , Therapeutics Company Profile , Morgan Stanley , Therapeutics Inc , Allspring Global Investments Holdings , Cantor Fitzgerald , Goldman Sachs Group , Free Report , Get Free Report , Director Jerome , Capital Partners , Global Investments Holdings , Retirement System , Rhumbline Advisers ,

Guided Therapeutics (OTCMKTS:GTHP) Shares Up 35.4%

Guided Therapeutics (OTCMKTS:GTHP) Shares Up 35.4%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Therapeutics Company Profile , Therapeutics Inc , Guided Therapeutics , Get Free Report , Guided Therapeutics Daily ,